Search results
Melanoma patients reveal dramatic stories for Skin Cancer Awareness Month: ‘I thought I was careful’
Fox News via Yahoo News· 7 days agoFor Skin Cancer Awareness Month, two melanoma patients shared their stories of how they overcame the...
Are you using sunscreen correctly?
The Dominion Post, Morgantown, W.Va. via Yahoo News· 5 days agoMay 18—Memorial Day weekend is on the horizon, and the unofficial start of summer brings promises of water, sun, splashing, grilled food and great fun with friends and family. And you have an ...
The Current State Of Skin Cancer
Women s Health· 11 hours agoThe American Academy of Dermatology also points out that the rates of melanoma in people under 50 are higher in women than in men. “The incidence of...
High-Stage cSCC: Outcomes Superior With Mohs vs WLE
Medscape· 21 hours agoMohs surgery appears to be superior to wide local excision (WLE) in patients with high-stage cutaneous squamous cell carcinoma (cSCC) ...
Adlai Nortye starts subject dosing in Phase II rectal cancer trial
Clinical Trials Arena via Yahoo Finance· 14 hours agoIn November last year, the company concluded the subject enrolment in the Phase III BURAN trial of...
Protect your skin in the sun: A warning during Skin Cancer Awareness month
ABC 3340 Birmingham· 2 days agoAccording to the Skin Cancer Foundation 1 in 5 Americans will have skin cancer before the age of 70....
Rutgers Cancer Institute and RWJBarnabas Health Set to Unveil Extensive, New Cancer Research...
FOX 23 News Albany· 3 hours agoClinicians and scientists from Rutgers Cancer Institute and RWJBarnabas Health will lead sessions...
Rutgers Cancer Institute and RWJBarnabas Health Se | Newswise
Newswise· 21 hours agoClinicians and scientists from Rutgers Cancer Institute and RWJBarnabas Health will lead sessions...
Phio Pharmaceuticals Announces Presentation at the Annual Meeting of the American Society of...
Digital Journal· 4 hours agoPhio is reporting on the completion of the first dose cohort for its on-going open-label Phase 1b clinical study (NCT 06014086) which is designed to evaluate the safety and tolerability of neoadjuvant ...
Precigen to Host a Webcast on June 3rd to Detail Pivotal Study Results of PRGN-2012 in Recurrent...
FOX21 Colorado Springs· 5 hours agoPrecigen, Inc. (Nasdaq: PGEN), a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of patients, today announced that the Company ...